Wells Fargo’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-17
| Closed | -$71 | – | 6626 |
|
2024
Q1 | $71 | Buy |
17
+1
| +6% | +$4 | ﹤0.01% | 6346 |
|
2023
Q4 | $73 | Buy |
16
+1
| +7% | +$5 | ﹤0.01% | 6402 |
|
2023
Q3 | $68 | Sell |
15
-2
| -12% | -$9 | ﹤0.01% | 6474 |
|
2023
Q2 | $95 | Buy |
17
+1
| +6% | +$6 | ﹤0.01% | 6570 |
|
2023
Q1 | $100 | Buy |
16
+5
| +45% | +$31 | ﹤0.01% | 6617 |
|
2022
Q4 | $166 | Hold |
11
| – | – | ﹤0.01% | 6345 |
|
2022
Q3 | $0 | Buy |
11
+1
| +10% | – | ﹤0.01% | 6462 |
|
2022
Q2 | $0 | Buy |
10
+2
| +25% | – | ﹤0.01% | 6629 |
|
2022
Q1 | $0 | Buy |
8
+1
| +14% | – | ﹤0.01% | 6769 |
|
2021
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 6755 |
|
2021
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 6704 |
|
2021
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 6623 |
|
2021
Q1 | $0 | Buy |
7
+4
| +133% | – | ﹤0.01% | 6569 |
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6208 |
|
2020
Q3 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 6039 |
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 5972 |
|
2020
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 5938 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 5932 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 5929 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 5920 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 5865 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5902 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 5935 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 5925 |
|
2016
Q2 | – | Sell |
-1
| Closed | -$2K | – | 5801 |
|
2016
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 5751 |
|
2015
Q4 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 5660 |
|